Publications & Abstracts

We recommend consideration of the DJBS as a therapy alternative for the treatment of adult patients (minimum age: 18 years) with type 2 diabetes...

To report Type 2 diabetes-related outcomes after the implantation of a duodenal-jejunal bypass liner device and to investigate the role of proximal...

Bariatric surgery reduces nonalcoholic fatty liver disease (NAFLD). We investigated the effects of duodenal-jejunal bypass liner (DJBL), nonsurgical...

We sought to identify clinical factors associated with weight loss in obese patients treated with the DJBL for 1 year.

To gain insight into the mediators involved, we investigated factors regulating glucose homeostasis in patients with type 2 diabetes treated with...

We conducted a nonsystematic review on worldwide articles published on the MEDLINE database to ascertain progress in the development and use of the...

To assess the safety of the DJBL and to evaluate its potential to affect glycemic control beneficially in subjects with T2DM who were not morbidly...

The purpose of this study was to evaluate the effect of the duodenal–jejunal bypass liner (DJBL), a 60-cm, impermeable fluoropolymer liner anchored...

To evaluate safety, weight loss, and cardiometabolic changes in obese subjects implanted with the duodenal-jejunal bypass liner (DJBL) for 1...

This is an interim report of an ongoing one year study. In a prospective, randomized, diet controlled, multicentre study, 77 subjects were included,...